Detalles de la búsqueda
1.
Bi38-3 is a novel CD38/CD3 bispecific T-cell engager with low toxicity for the treatment of multiple myeloma.
Haematologica
; 106(4): 1193-1197, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32675220
2.
Dual Chimeric Antigen Receptor T Cells Targeting CD38 and SLAMF7 with Independent Signaling Demonstrate Preclinical Efficacy and Safety in Multiple Myeloma.
Cancer Immunol Res
; 12(4): 478-490, 2024 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38289260
3.
CAR-T cells derived from multiple myeloma patients at diagnosis have improved cytotoxic functions compared to those produced at relapse or following daratumumab treatment.
EJHaem
; 3(3): 970-974, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36051036
4.
SYK Inhibition Induces Apoptosis in Germinal Center-Like B Cells by Modulating the Antiapoptotic Protein Myeloid Cell Leukemia-1, Affecting B-Cell Activation and Antibody Production.
Front Immunol
; 9: 787, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29740433
5.
Co-stimulation Blockade Plus T-Cell Depletion in Transplant Patients: Towards a Steroid- and Calcineurin Inhibitor-Free Future?
Drugs
; 76(17): 1589-1600, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27785759
6.
Subcellular localization of PUMA regulates its pro-apoptotic activity in Burkitt's lymphoma B cells.
Oncotarget
; 6(35): 38181-94, 2015 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26431330
7.
Cloning and expression of candidate allergens from Culicoides obsoletus for diagnosis of insect bite hypersensitivity in horses.
Vet Immunol Immunopathol
; 153(3-4): 227-39, 2013 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23561552
Resultados
1 -
7
de 7
1
Próxima >
>>